J. Greenblatt

T Lymphocyte-Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years

S. Rosenberg, W. Anderson, M. Clerici, 1995, Science.

Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation.

A. Nienhuis, J. O’Shaughnessy, C. Dunbar, 1995, Blood.

Clinical trial design and regulatory issues for therapeutic cancer vaccines.

J. Greenblatt, H. Streicher, Jan Casadei, 2005, Cancer treatment and research.

Retroviral gene transduction of adult peripheral blood or marrow-derived CD34+ cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivo.

K. Cowan, J. O’Shaughnessy, J. Zujewski, 1997, Blood.

U.S. Department of Health and Human Services National Institutes of Health Recombinant DNA Advisory Committee: Minutes of meeting: December 6, 2001

X. Breakefield, E. Juengst, R. Macklin, 2002 .

Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome.

J. Berzofsky, J. Minna, D. Carbone, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Accessing investigational anticancer agents outside of clinical trials.

J. Greenblatt, M. Montello, D. Shoemaker, 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Prenatal gene transfer: Scientific, medical, and ethical issues: A report of the recombinant DNA advisory committee

L. Andrews, X. Breakefield, E. Juengst, 2000 .